These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 26884839)
1. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy. Wang C; Li Q; Zhen J; Xu Y; Sun S Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. Zhang W; Li Q; Wang L; Yang X Pediatr Nephrol; 2008 Dec; 23(12):2185-94. PubMed ID: 18791746 [TBL] [Abstract][Full Text] [Related]
3. P2X7R antagonist protects against renal injury in mice with adriamycin nephropathy. Zhu Y; Liu M; Xun W; Li K; Niu X Exp Ther Med; 2022 Feb; 23(2):161. PubMed ID: 35069842 [TBL] [Abstract][Full Text] [Related]
4. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression. Liu Y; Ji Z J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594 [TBL] [Abstract][Full Text] [Related]
5. Effect of Simvastatin on Lipid Accumulation and the Expression of CXCL16 and Nephrin in Podocyte Induced by Oxidized LDL. Wang L; Yao X; Li Q; Sun S J Invest Surg; 2018 Apr; 31(2):69-74. PubMed ID: 28635512 [TBL] [Abstract][Full Text] [Related]
6. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice. Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875 [TBL] [Abstract][Full Text] [Related]
7. [Effects of huangkui capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy]. Zhao Q; Wan YG; Sun W; Wang CJ; Wei QX; Chen HL; Meng XJ Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2926-34. PubMed ID: 23270236 [TBL] [Abstract][Full Text] [Related]
8. Mixed hydroalcoholic extracts of Mohebbati R; Shafei MN; Beheshti F; Soukhtanloo M; Roshan NM; Anaeigoudari A; Parhizgar S; Hosseinian S; Khazdeir MR; Rad AK Saudi J Kidney Dis Transpl; 2017; 28(6):1270-1281. PubMed ID: 29265038 [TBL] [Abstract][Full Text] [Related]
9. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity. Huang X; Xue H; Ma J; Zhang Y; Zhang J; Liu Y; Qin X; Sun C J Cell Mol Med; 2019 Jun; 23(6):4443-4453. PubMed ID: 30993911 [TBL] [Abstract][Full Text] [Related]
10. Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy. Liu H; Sun W; Gu LB; Tu Y; Yu BY; Hu H Chin J Integr Med; 2017 Apr; 23(4):279-287. PubMed ID: 26453563 [TBL] [Abstract][Full Text] [Related]
11. Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice. Han X; Dai R; Zhai Y; Shen Q; Sun L; Liu H; Xu H Biochem Biophys Res Commun; 2019 Aug; 516(3):812-818. PubMed ID: 31256934 [TBL] [Abstract][Full Text] [Related]
12. Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy. Niu Q; Guo Z; Liang Y; Zuo L Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408958 [TBL] [Abstract][Full Text] [Related]
13. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721 [TBL] [Abstract][Full Text] [Related]
14. Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy. Ai S; Lin YY; Zheng J; Qiu CX; Liu YJ; Lin X Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706571 [TBL] [Abstract][Full Text] [Related]
15. [Effect of Buyang Huanwu Decoction on mRNA Expressions of Aorta Rho Kinase and NF-κB p65 in Atherosclerosis Model Rats]. Zhang HZ; Li L; Jiao R; Zhang Y; Qian Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Dec; 35(12):1495-500. PubMed ID: 26882614 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol mitigates pancreatic TF activation and autophagy-mediated beta cell death via inhibition of CXCL16/ox-LDL pathway: A novel protective mechanism against type 1 diabetes mellitus in mice. Darwish MA; Abdel-Bakky MS; Messiha BAS; Abo-Saif AA; Abo-Youssef AM Eur J Pharmacol; 2021 Jun; 901():174059. PubMed ID: 33794215 [TBL] [Abstract][Full Text] [Related]
17. Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Wang Y; Wang Y; Feng X; Bao S; Yi S; Kairaitis L; Tay YC; Rangan GK; Harris DC Kidney Int; 2001 Mar; 59(3):975-84. PubMed ID: 11231352 [TBL] [Abstract][Full Text] [Related]
18. Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy. Jovanovic D; Dimitrijevic J; Varagic J; Jovovic D; Starcevic A; Djukanovic L Ren Fail; 1998 May; 20(3):451-8. PubMed ID: 9606733 [TBL] [Abstract][Full Text] [Related]
19. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013 [TBL] [Abstract][Full Text] [Related]
20. A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Qin XH; Lee VW; Wang YP; Zheng GP; Wang Y; Alexander SI; Harris DC Kidney Int; 2006 Oct; 70(7):1244-50. PubMed ID: 16900095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]